Session 8 - Neoplasia 1 and 2 Flashcards

1
Q

Definitions:

  • Hyperplasia
  • Regeneration
  • Tumour
  • Neoplasia
  • Oncology
A
  • Hyperplasia: Increase in tissue or organ size due to increased cell numbers
  • Regeneration: ​renewing or restoring something, especially after it has been damaged or lost
  • Tumour: A swelling (remember from inflammation), any clinically detectable lump or swelling
  • Neoplasm: Literally means ‘new growth’, just one type of tumour. A neoplasm is an abnormal growth of cells that persisits after the initial stimulus is removed.
  • Oncology: The study of tumours and neoplasms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Definitions surrounding the word neoplasm:

  • Benign neoplasm
  • Malignant neoplasm
  • Metastasis
  • Cancer
  • Dyplasia
  • —- potential characteristics with dysplasia?
A
  • Benign neoplasm: Gross and microscopic appearances are considered to be innocent, implying that it will remain localised and will not spread to other sites
  • Malignant neoplasm: An abnormal growth of cells that persists after the initial stimulus is removed and invades surrounding tissue with the potential to spread to distant sites
  • Metastasis: Malignant neoplasm that has spread from its original site to a new non-contiguous site
  • Cancer: a malignant neoplasm (colloquial)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Primary vs secondary - define

A
  • The original location of the malignant neoplasm is the primary site
  • The place to which it has spread is the secondary site.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Benign vs malignant

  • differences in characteristics
  • differntiation…
A

Benign vs malignant:
Differences in — • Behaviour • Appear different to the naked eye • Differentiation
- Benign neoplasms remain confined to their site of origin and do not produce metastases
​- Malignant neoplasms invade and have the potential to metastasise

Type/mode of growth:
Benign tumours
•Grow in a confined local area
•They have a pushing outer margin
•Rarely dangerous (location)
Malignant tumours
•Irregular outer margin and shape
•May have ulcerations and necrosis
•Infiltrative

Differentiation = the process of becoming different by growth or development (PIC below)
•Benign neoplasms closely resemble the parent tissue – well differentiated •Malignant neoplasms range from well to poorly differentiated, dependent on how closely they resemble the cell of origin.
•Cells with no resemblance to any tissue are called anaplastic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Differntiation
With worsening differntiation, the individual cells have…

A
  • Increasing nuclear size
  • Increased nuclear to cytoplasmic size
  • Increased nuclear staining (hyperchromasia)
  • Increased mitotic figures
  • Abnormal mitotic figures (Mercedes Benz)
  • Variation in size and shape of cells and nuclei (pleomorphism)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Differntiation scales…

  • Grade
  • Prostate (name of grading system)
  • Brest (name of grading system)
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dyplasia - more detail

  • Define and characteristics
  • Stages of dysplasia in the epidermis
A

Dyplasia = Dysplasia is the abnormal maturation of cells within a tissue, the cells show disordered tissue organisation, and it is reversible. It can be pre-neoplastic.

  • — Characteristics: considerable pleomorphism, larger hyperchromatic nuclei and high nuclear to cytoplasmic ratio
  • — Mild, moderate and severe - worsening differention

Order:
Normal -> Dyplasia -> Carcinoma in situ -> invasive cancer (invasive cancer - the basement membrane has been invaded)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Dysplasia - example of the cervix and scoring system

A
CIN I - cervical intra-epithelial neoplasia 1 (dyplasia affects the lower third of the epithelium first)
CIN II: Lower 2 thirds
CIN III (also called carcinoma in situ): Full thickness of epithelium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do we get neoplasms?

A

Carcinogenesis (NON-lethal genetic damage)

Accumulation of mutations in somatic cells

  • Mutations are caused by initiators, mutagenic agents
  • Promoters then cause cell proliferation
  • A tumour is formed by the clonal expansion of a single precursor cell that has incurred genetic damage

Initiators -> Promotors -> Proliferation -> Porgression

  • A neoplasm then emerges from this group of cells by a process called progression, this is characterised by the accumulation of even more mutations.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

List of potential initiators

  • Recap of difference between initiators and promotors
A

• Chemicals:
- Smoking
- Alcohol consumption
- Diet and obesity
• Infectious agents
- HPV
• Radiation
• Inherited mutations

*Many initiators can also act as promoters

Initiator: Induce first mutation
Promoter: Increase population size
Some carcinogens are initiators and promoters, some are one or the other

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which genes are affected - mutations here to occur in key genes…

A

There are FOUR class of normal regulatory genes:

  1. • Growth promoting proto-oncogenes
  2. • Growth inhibiting tumour suppressor genes
  3. • Genes that regulate programmed cell death (apoptosis)
  4. • Genes involved in DNA repair
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  1. Proto-oncogenes
    - explain
    - examples
A
  • Multiple functions but all participate at some level in signalling pathways that drive proliferation
  • Mutations that activate these generally cause an excessive increase in one or more normal functions
  • Sometimes they impart a completely new function on the affected gene
  • “Gain-of-function” mutations
  • Oncogenes are created by mutations in proto-oncogenes and encode proteins called oncoproteins that have the ability to promote cell growth in the absence of normal growth promoting signals
  • They can transform cells despite a normal copy of the same gene
  • Oncogenes are dominant over their normal counterparts

Protooncogene or oncoprotein mutation -> Oncogenes (oncogenes have the ability to promote cell growth in the absence of normal growth promoting signals)

Examples: BRAF mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  1. Tumour Suppressor Genes
    - Explain
    - Example
  2. Apoptosis Regulating Genes
    - Explain
A
  1. Tumour Suppressor Genes:
    • Normal function is to stop cell proliferation
    • Generally cause a ‘loss-of-function’
    • In most instances both alleles must be damaged for transformation to occur
    • Abnormalities in these genes leads to failure of growth inhibition

Examples - p53 (a tumour suppressor gene)

  1. Apoptosis Regulating Genes
    • May acquire abnormalities that result in less cell death and enhanced survival of cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  1. DNA Repair Genes
    - Explain
A
  • Loss of function mutations
  • Contribute indirectly to carcinogenesis
  • Impair the ability of the cell to recognise and repair non-lethal genetic damage in other genes
  • As a result affected cells acquire mutations at an accelerated rate, a state referred to as a mutator phenotype and is marked by genomic instability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Naming Neoplasms

  • What does this take into account?
  • In general - Benign tumour, Malignant tumour name
A

Naming -
Takes into account:
• The neoplasms site of origin
• Benign or malignant
• Sometimes the gross morphology

General:
• Benign tumours end in –oma
• Malignant tumours end in
= carcinoma (if epithelial) – 90% of neoplasms
= sarcoma (if stromal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Overarching names

  • Benign
  • Malignant
A
17
Q

Connective tissue neoplasm—-
Connective tissue neoplasm - Benign:

  • Smooth muscle
  • Fibrous tissue
  • Bone
  • Cartilage
  • Fat
  • Nerve
  • Nerve sheath
  • Glial cells

Connective tissue neoplasm - Malignant:

  • Smooth muscle
  • Fibrous tissue
  • Bone
  • Cartilage
  • Fat
  • Glial cells
A

Benign:

  • Smooth muscle: Leiomyoma
  • Fibrous tissue: Fibroma
  • Bone: Osteoma
  • Cartilage: Chondroma
  • Fat: Lipoma
  • Nerve: Neuroma
  • Nerve sheath: Neurofibroma
  • Glial cells: Glioma

Malignant:

  • Smooth muscle: Leiomyosarcoma
  • Fibrous tissue: Fibrosarcoma
  • Bone: Osteosarcoma
  • Cartilage: Chondrosarcoma
  • Fat: Liposacroma
  • Glial cells: Malignant glioma
18
Q

Tissue of origin:
Blood vessel
Lymph vessels
Smooth muscle
Striated muscle
Stratified squamous epithelium
Epithelial lining of glands or ducts
Urinary tract epithelium
Blood cells
Lymphoid tissue
Plasma cells

A
19
Q

Germ cell neoplasms

  • Testis
  • Ovary
A
20
Q

Definitions

  • Invasion
  • Metastasis
  • Tumour burden
A
  • Invasion: Breach of the basement membrane with progressive infiltration and destruction of surrounding tissue
  • Metastasis: Spread of tumour to sites that are physiocally discontinous from the primary tumour (unequivocally marks a tumour as malignant)
  • Tumour burden: for malignant neoplasms - overtime, increasing tumour burden
21
Q

How does a neoplasm invade and metastasise?

A
  1. Grow and invade at the primary site
  2. Enter a transport system and lodge at a secondary site
  3. Grow at the secondary site to form a new tumour (colonisation)
22
Q

What does a carcinoma cell need in order to be ‘successful’ at invasion?

A

For malignant cells to invade in to surrounding tissues they require:

  • Altered cellular adhesion
    • Decreased expression of E-cadherin reduces the cell-cell adhesion.
    • Changes to expression of integrin receptors alters the adhesion between cells and extracellular matrix.
  • Increased secretion of proteolytic enzymes
    • Matrix metalloproteinases (MMPs) are enzymes secreted by malignant cells to enable them to breakdown surrounding connective tissue.
  • Increased cellular motility
    Involves changes in the actin cytoskeleton

In doing so the cell takes on a phenotype more akin to a mesenchymal cell/stromal cell than an epithelial cell and this is epithelial to mesenchymal transition

23
Q

How does it spread to distant sites - metastasis

  • Which route do carcinomas and sarcomas commonly spread by?
A

There are several different routes of metastasis:

  • Blood stream (haemotogenous spread)
  • Lymphatics
  • Transcoelomic spread (across a body cavity such as through the peritoneal, pleural or pericardial cavities).
  • Carcinomas: Lymph node, then blood stream
  • Sarcomas: Blood stream first
24
Q

Secondary site - At the secondary site, the malignant cells have to grow (colonisation)

  • What is the greatest barrier to successful metastasis
  • Surviving microscopic deposits that fail to grow are called…
A

- What is the greatest barrier to successful metastasis:
​• Failed colonisation is considered to be the greatest barrier to successful metastasis
• Most malignant cells lodge at secondary sites as tiny clinically undetectable cell clusters that either die or fail to grow into detectable tumours
- Surviving microscopic deposits that fail to grow are called: micrometastases
—- this is why people often aren’t said to be ‘cured’ of cancer, as can’t be sure if there are any micrometases

25
Q
  1. Blood stream metastasis
    - Where secondary site?
    - Which secondary sites for blood stream metastasis
    - Which types of maligant neoplasms often spread to the bone?
A

Secondary tumours form in organs which are perfused by blood that has drained from the site of the tumour. For example, GI malignancies often spread to the liver due to drainage by the portal vein which takes blood to the liver.

Metastases through the blood often form masses at: the liver, lungs, bone and brain due to blood flow patterns.

Bone is commonly favoured by carcinomas originating from: lung, breast, thyroid, kidney and prostate.
Metastases from the former four organs cause lytic lesions which means they decrease bone mass, whereas metastases from the prostate causes sclerotic lesions – increase bone mass. These changes can be visible on x-rays.

26
Q
  1. Lymphatic Metastasis:
  2. Transcoelomic spread metastasis:
A

Lymphatic metastasis:
Malignant cells enter lymph nodes through the afferent lymph vessels and settle at the periphery of the node. They grow inwards and the node is gradually replaced by cancer cells and connective tissue. This can result in lymphadenopathy and blockage of lymph flow leading to lymphoedema in the region drained by the blocked lymph vessels

**Transcoelomic spread metastasis:** 
This type of metastasis occurs within **pleural**, **pericardial** and **peritoneal** cavities. This results in formation of a protein rich effusion (**exudate**) within the cavity. This fluid also contains malignant cells causing the exudate, so the fluid can therefore by **aspirated** and used for **diagnosis**.
Peritoneal effusions (ascites) are commonly caused by **ovarian tumours**, although can also be caused by any abdominal tumour. Pleural and pericardial effusions are often caused by **breast** and **lung** cancers
27
Q

What determines the site of a secondary tumour?

A

Regional drainage of blood, lymph or caulomic fluid

  • For lymphatic metastasis this is predictably to draining lymph nodes - Breast cancer goes to the ipsilateral axillary lymph nodes
  • For transcoelemic spread this is predictably to other areas in the coelemic space or to adjacent organs
  • For blood-borne metastasis this is sometimes (but not always) to the next capillary bed that the malignant cells encounter.
28
Q

What is the ‘seed and soil’ phenomenon?

A
  • May explain the unpredictable distribution of blood-borne metastases
  • Due to interactions between malignant cells and the local tumour environment at the secondary site
    …in order for a metastatic deposit to develop, it has to interact between malignant cells and local tumour environment at the secondary site, if the niche is not ‘right’, it will not metastasis
29
Q

Reminder *as really important*
General rule for metatasis
- Common sites of blood borne metastasis
- Common neoplasms that spread to bone

A

​• Carcinomas tend to spread via lymphatics first
• Sarcomas spread via blood stream
Common sites of blood borne metastasis are lung, bone, liver and brain
Common neoplasms that spread to bone:
Important to know the more common neoplasms that spread to the bone as these can be detected on plain films and be the presenting symptom:
– Breast – Bronchus – Kidney – Thyroid – Prostate

Majority are osteolytic lesions due to destruction of the bone tissue.
Prostate cancer actually causes osteosclerotic metastases as it causes increased production of disorganised abnormal bone

30
Q

Personalities of malignant neoplasms

A

Some malignant neoplasms are more aggressive and metastasise very early in their course
• Small cell carcinoma of the bronchus for example is very aggressive and presents early with widespread systemic metastases or is at the very least locally advanced
• Others almost never metastasise e.g. basal cell carcinoma of the skin

31
Q

Evasion of the host defence by tumour cells

A

• Tumour cells can be recognised by the immune system as non-self and destroyed.
• This is mediated by predominantly cell mediated mechanisms
• Tumour antigens are presented on the cell surface of major histocompatibility complex molecules (MHC) and are recognised by CD8 + cytotoxic T cells
• Immunosuppressed patients are at increased risk for the development of cancer
• However in immunocompetent patient’s tumours can avoid the immune system via several mechanisms
– The loss or reduced expression of histocompatibility antigens
– Expression of certain factors that suppresses the immune system
– Failure to produced tumour antigen
• This is the current concepts behind immunotherapy agents

32
Q

Effects of neoplasms

  • local
  • systemic
  • paraneoplastic
  • hypercalcaemia
  • miscellaneous
A
  • *Local effects: LOCATION IS KEY**
    1. Direct invasion and destruction of normal tissue
    2. Ulceration at a surface leading to bleeding
    3. Compression of adjacent structures
    4. Blocking tubes and orifices
    5. Raised pressure due to tumour growth or swelling (brain)

Systemic effects:
• Increased tumour burden results in a parasitic effect on the host
• Together with secreted factor such as cytokines:
– Reduced appetite and weight loss (cachexia)
– Malaise
– Immunosuppression
– Thrombosis
• Production of hormones
– Usually benign tumours

Paraneoplastic Syndromes:
Some cancer bearing individuals develop signs and symptoms that cannot readily be explained by the anatomic distribution of the tumour or by the production of hormones from the tissue in which the tumour arose.
Affect approximately 10% of people with cancer
Important because:
- May be the earliest manifestation of an occult neoplasm
- Can cause significant clinical problems and be fatal
- Can mimic metastatic disease and confound treatment

Hypercalcaemia:
– Probably the most common
– 2 processes:
• Osteolysis – induced by cancer due to either primary bone lesions such as myeloma or secondary metastases
• Production of calcaemic humoral substances by extraosseous neoplasms

Miscellaneous:
– Neuropathies affecting brain and peripheral nerves
– Skin problems e.g. pruritus and abnormal pigmentation
– Fever
– Clubbing
– Myositis